Gero vs LIPUM AB
Gero
AI-driven drug discovery company focused on therapies targeting age-related diseases
147 employees · est. 2018 · Palo Alto, United States
LIPUM AB
We have developed a biological drug SOL-116 for treatment of chronic inflammatory diseases
15 employees · est. 2010 · Umea, Sweden
LIPUM AB is the older company (2018 vs 2010); Gero is the larger of the two.
5 signals in the last 90 days
Side-by-Side Comparison
| Metric | Gero | LIPUM AB |
|---|---|---|
| Founded | ||
| Founded | 2018 | 2010 older |
| Headquarters | ||
| Headquarters | Palo Alto, United States | Umea, Sweden |
| Employees | ||
| Employees | 147 larger | 15 |
| Industry | ||
| Industry | AI, Biotechnology, Insurtech | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series B | Post-IPO Equity |
| Total Funding | ||
| Total Funding | $25.20M | $121.25M |
| Funding Rounds | ||
| Funding Rounds | 4 | 4 |
| Services | ||
| Services | Developing drugs targeting aging, AI models for disease progression, Collaborative drug discovery with pharma companies | Development of anti-inflammatory drugs, Clinical development and trials of SOL-116, Scientific advisory and consultancy |
| Target Customers | ||
| Target Customers | Pharmaceutical companies, Healthcare researchers, Investors interested in biotechnology, Aging and longevity research institutions | Patients with chronic inflammatory diseases, Healthcare providers, Medical researchers, Investors in life sciences |
| Taxonomy | ||
| Taxonomy | AI Drug DiscoveryAge-related DiseasesPreclinical StageDisease PhenotypesReal-world Human DataGenetic Study +8 | Biological Drug DevelopmentChronic Inflammatory DiseasesRheumatoid Arthritis TreatmentJuvenile Idiopathic ArthritisOrphan Drug DesignationAutoimmune Diseases +9 |
| Website | ||
| Website | gero.ai | lipum.se |
About Gero
Gero, founded in 2018, is an AI-driven drug discovery company focused on therapies targeting age-related diseases. The company is headquartered in the United States and operates at the intersection of AI, Biotechnology, Insurtech, and Pharmaceutical industries. At its core, Gero aims to eliminate a...
About LIPUM AB
LIPUM AB, a trailblazer in the Biotechnology and Health Care sectors, has developed SOL-116, a groundbreaking biological drug targeting chronic inflammatory diseases. Since its inception in 2010, the company has been committed to improving the quality of life for millions affected by these debilitat...
Also comparing in this category
Comparing more than these two?
Get Gero, LIPUM AB and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Gero compare?
A PDF of Gero and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Frequently Asked Questions
Compare Gero with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Gero on 15 Jun 2026, and LIPUM AB on 14 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
